Nicholas P Anagnou
Overview
Explore the profile of Nicholas P Anagnou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalafati E, Drakopoulou E, Anagnou N, Pappa K
Cells
. 2023 Jul;
12(14).
PMID: 37508503
Cervical cancer represents one of the most important malignancies among women worldwide. Current therapeutic approaches for cervical cancer are reported not only to be inadequate for metastatic cervical cancer, but...
2.
Drakopoulou E, Georgomanoli M, Lederer C, Panetsos F, Kleanthous M, Voskaridou E, et al.
Viruses
. 2022 Dec;
14(12).
PMID: 36560719
We have previously demonstrated that both the original γ-globin lentiviral vector (LV) GGHI and the optimized GGHI-mB-3D LV, carrying the novel regulatory elements of the 3D HPFH-1 enhancer and the...
3.
Drakopoulou E, Anagnou N, Pappa K
Cancers (Basel)
. 2022 Jul;
14(13).
PMID: 35805007
Despite the major advances in screening and therapeutic approaches, gynaecological malignancies still present as a leading cause of death among women of reproductive age. Cervical cancer, although largely preventable through...
4.
Kalafati E, Papanikolaou E, Marinos E, Anagnou N, Pappa K
Mol Med Rep
. 2022 May;
25(6).
PMID: 35506451
The Mimivirus is a giant virus that infects amoebae and was long considered to be a bacterium due to its size. The viral particles are composed of a protein capsid...
5.
Magkana M, Mentzelopoulou P, Magkana E, Pampanos A, Vrachnis N, Kalafati E, et al.
Anticancer Res
. 2022 Apr;
42(5):2599-2606.
PMID: 35489732
Background/aim: To evaluate p16/Ki-67 dual-staining performance for detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) in the management of women with minor cervical abnormalities. Patients And Methods: All...
6.
Yannaki E, Psatha N, Papadopoulou A, Athanasopoulos T, Gravanis A, Roubelakis M, et al.
Hum Gene Ther
. 2021 Oct;
32(19-20):1120-1137.
PMID: 34662232
Gene therapy is a relatively novel field that amounts to around four decades of continuous growth with its good and bad moments. Currently, the field has entered the clinical arena...
7.
Iolascon A, Rivella S, Anagnou N, Camaschella C, Swinkels D, Muckenthaler M, et al.
Hemasphere
. 2021 Sep;
5(7):e607.
PMID: 34522846
No abstract available.
8.
Pappa K, Daskalakis G, Anagnou N
Sci Rep
. 2021 Sep;
11(1):17718.
PMID: 34489482
Both HPV-positive and HPV-negative cervical cancers are associated with aberrant metabolism, although the oncogenic drivers remain elusive. Here we show the assessment of the metabolomic profiles of four distinct cervical...
9.
Taher A, Iolascon A, Matar C, Bou-Fakhredin R, De Franceschi L, Cappellini M, et al.
Hemasphere
. 2020 Sep;
4(4):e446.
PMID: 32885142
Rare inherited anemias are a subset of anemias caused by a genetic defect along one of the several stages of erythropoiesis or in different cellular components that affect red blood...
10.
Pappa K, Lygirou V, Kontostathi G, Makridakis M, Vougas K, Sfakianakis A, et al.
Oncol Rep
. 2019 Sep;
42(4):1441-1450.
PMID: 31524267
Cervical cancer remains the fourth most common and most lethal type of cancer in women, despite the applied regular screening and prevention strategies, while the available treatment schemes still pose...